Ethical issues in emerging new treatments such as growth hormone therapy for children with Down syndrome and Prader-Willi syndrome.
As new therapies and new applications of existing drugs expand, pediatricians are often in the position of trying to decide when and whether use of a new treatment is appropriate. In this paper, we address this dilemma by focusing on ethical issues in the use of growth hormone therapy for children with Down syndrome and Prader-Willi syndrome as an example. We discuss six major questions that link scientific and ethical considerations in analyzing these difficult issues.
Kodish
E
E
Rainbow Babies and Childrens Hospital, Cleveland, OH, USA.
Cuttler
L
L
D002648:Child; D004314:Down Syndrome / Q000628:therapy*; D004992:Ethics, Medical; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D011218:Prader-Willi Syndrome / Q000628:therapy*
D019382:Human Growth Hormone